Co-Chair
Peter R. Farina, Ph.D., senior vice president, development, Boehringer Ingelheim Pharmaceuticals, Inc.

Co-Chair
David W. Keiser, president and chief operating officer, Alexion Pharmaceuticals, Inc.

President & CEO
Paul R. Pescatello, J.D., Ph.D., president & CEO, CURE

Secretary
Bruce D. Alexander, vice president & director of New Haven and state affairs, Yale University

Treasurer
Michelle Bowman, partner, PricewaterhouseCoopers LLP


Executive Committee Members

Bruce D. Alexander, vice president & director of New Haven and state affairs, Yale University

Peter R. Farina, Ph.D., senior vice president, development, Boehringer Ingelheim Pharmaceuticals, Inc.

David W. Keiser, president and chief operating officer, Alexion Pharmaceuticals, Inc.

Frank J. Marco, J.D., partner, Wiggin and Dana LLP

Harry H. Penner, Jr., president & CEO, Marinus Pharmaceuticals, Inc.

Paul R. Pescatello, J.D., Ph.D., president & CEO, CURE


Board of Directors

Daniel D. Adams, president & CEO, Protein Sciences Corporation

Bruce D. Alexander, vice president & director of New Haven and state affairs, Yale University

Timothy F. Bannon, special counsel, Purdue Pharma L.P.

Heather J. Bessoff White, D.V.M., assistant secretary, Connecticut Veterinary Medical Association

Edward M. Bowman, Jr., chairman, Connecticut Innovations

Michelle Bowman, partner, PricewaterhouseCoopers LLP

Peter Farina, Ph.D., senior vice president, development, Boehringer Ingelheim Pharmaceuticals, Inc.

Susan Froshauer, Ph.D., president & CEO, Rib-X Pharmaceuticals, Inc.

Judith B. Greiman, president, Connecticut Conference of Independent Colleges

Michael J. Hogan, Ph.D. , president, University of Connecticut

David W. Keiser, president & chief operating officer, Alexion Pharmaceuticals, Inc.

Michael D. Kishbauch, president and CEO, Achillion Pharmaceuticals, Inc.

Hollis D. Kleinert, Ph.D., president, Kleinert Scientific/Commercial Consultations

Frank J. Marco, J.D., partner, Wiggin and Dana LLP

Christopher K. McLeod, president and CEO, 454 Life Sciences

Sandra S. Oliver, vice president of public policy & state government affairs, Bayer HealthCare

Harry H. Penner, Jr., president & CEO, Marinus Pharmaceuticals, Inc.

Paul R. Pescatello, J.D., Ph.D., president & CEO, CURE

Gordon P. Polley, chairman, The Institutes for Pharmaceutical Discovery, LLC

Kevin Rakin, president, Advanced BioHealing

John E. Rossi, senior vice president, emerging growth/technology, Webster Bank

Jonathan M. Rothberg, Ph.D., chairman of the board, 454 Life Sciences

Seth A. Rudnick, M.D., general partner, Canaan Partners

David I. Scheer, president, Scheer and Company

John S. Swen, vice president, science policy & public affairs, Pfizer, Inc.

James P. Torgerson , chairman, president & CEO, UIL Holdings Corporation